Therapy-related Myelodysplastic Syndrome (t-MDS) in a Patient with Anaplastic Astrocytoma: Successful Treatment with Allogeneic Bone Marrow Transplant

被引：0

作者：

Lisa R. Rogers

Nalini Janakiraman

Claude Kasten-Sportes

Mark L. Rosenblum

机构：

[1] The Hermelin Brain Tumor Center and Henry Ford Hospital,Department of Neurosurgery; Department of Neurology

[2] The Hermelin Brain Tumor Center and Henry Ford Hospital,Department of Medical Oncology

来源：

Journal of Neuro-Oncology | 2001年 / 53卷

关键词：

antineoplastic agents; brain neoplasms; leukemia; myelodysplastic syndromes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objective and importance Therapy-related myelodysplastic syndrome (t-MDS) is a rare and typically fatal complication of therapy for cancer, including brain tumors. We report successful therapy of t-MDS that developed after treatment for an anaplastic astrocytoma.

引用

页码：55 / 59

页数：4

共 50 条

[1] Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: Successful treatment with allogeneic bone marrow transplant
Rogers, LR
Janakiraman, N
Kasten-Sportes, C
Rosenblum, ML
JOURNAL OF NEURO-ONCOLOGY, 2001, 53 (01) : 55 - 59
[2] Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7
Renneboog, B
Hansen, V
Heimann, P
DeMulder, A
Janssen, F
Ferster, A
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (03) : 696 - 698
[3] Therapy-related myelodysplastic syndrome (t-MDS) following treatment of acute myeloid leukemia (AML)
Arana-Yi, C.
Block, A. W.
Sait, S. N.
Ford, L. A.
Barcos, M.
Baer, M. R.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[4] Clinical Features and Outcomes of 666 Cases with Therapy-Related Myelodysplastic Syndrome (t-MDS)
Abd El-Fattah, Mohamed
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (01) : 83 - 90
[5] Clinical Features and Outcomes of 666 Cases with Therapy-Related Myelodysplastic Syndrome (t-MDS)
Mohamed Abd El-Fattah
Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 83 - 90
[6] RISK STRATIFICATION OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS): A REPORT ON BEHALF OF THE MDS CLINICAL RESEARCH CONSORTIUM
Komrokji, R.
Zeidan, A.
Al Ali, N.
Padron, E.
Lancet, J.
Steensma, D.
Dezern, A.
Roboz, G.
Jabbour, E.
Sekeres, M.
Garcia-Manero, G.
List, A.
LEUKEMIA RESEARCH, 2015, 39 : S158 - S159
[7] CLINICAL CHARACTERISTICS, TREATMENT AND OUTCOMES OF PATIENTS WITH THERAPY-RELATED MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKAEMIA (T-MDS/AML)
Maung, S.
Burke, C.
Hayde, J.
Desmond, R.
McHugh, J.
Enright, H.
HAEMATOLOGICA, 2015, 100 : 485 - 486
[8] A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS)
Kuendgen, A.
Nomdedeu, M.
Tuechler, H.
Garcia-Manero, G.
Komrokji, R.
Sekeres, M.
Della Porta, M.
Cazzola, M.
Dezern, A.
Roboz, G.
Steensma, D.
Van De Loosdrecht, A.
Malcovati, L.
Schlenk, R.
Grau, J.
Calvo, X.
Blum, S.
Pereira, A.
Valent, P.
Costa, D.
Giagounidis, A.
Xicoy, B.
Dohner, H.
Platzbecker, U.
Pedro, C.
Lubbert, M.
Oiartzabal, I.
Diez-Campelo, M.
Cedena, M. T.
Machherndl-Spandl, S.
Lopez-Pavia, M.
Martinez-De-Sola, M.
Stauder, R.
Merchan, B.
Ganster, C.
Schroeder, T.
Voso, M. T.
Pfeilstocker, M.
Sill, H.
Hildebrandt, B.
Esteve, J.
Cobo, F.
Sole, F.
Germing, U.
Greenberg, P.
Haase, D.
Sanz, G.
LEUKEMIA RESEARCH, 2023, 128
[9] CYTOGENETIC STUDY IN THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS) AND ACUTE NONLYMPHOCYTIC LEUKEMIA (T-ANLL)
SOZZI, G
MIOZZO, M
ORAZI, A
CALDERONE, C
CASTELLANO, M
VIVIANI, S
SANTORO, A
PIEROTTI, MA
DELLAPORTA, G
BRITISH JOURNAL OF CANCER, 1990, 61 (03) : 425 - 428
[10] Therapy-related myelodysplastic syndrome after allogeneic BMT: successful treatment by donor lymphocyte infusions
D Roos-Weil
S Nguyen
M Uzunov
D Bories
E Chapiro
F Nguyen-Khac
J-P Vernant
N Dhédin
Bone Marrow Transplantation, 2010, 45 : 1471 - 1473

← 1 2 3 4 5 →